Antipsychotic Drug Use Among Nursing Home Residents Taking Rivastigmine
- 31 January 2006
- journal article
- Published by Elsevier BV in Journal of the American Medical Directors Association
- Vol. 7 (1), 12-16
- https://doi.org/10.1016/j.jamda.2005.04.007
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Risk of Antipsychotic Drug Use in Patients with Alzheimer???s Disease Treated with RivastigmineDrugs & Aging, 2004
- Olanzapine as a treatment of neuropsychiatric disorders of Alzheimer's disease and other dementias: A 24-month follow-up of 68 patientsAmerican Journal of Alzheimer's Disease and Other Dementias®, 2003
- Gabapentin for the Treatment of Behavioural Alterations in DementiaDrugs & Aging, 2003
- Mood stabilizers in Alzheimer’s disease: symptomatic and neuroprotective rationalesAdvanced Drug Delivery Reviews, 2002
- Butyrylcholinesterase: An Important New Target in Alzheimer's Disease TherapyInternational Psychogeriatrics, 2002
- Use of drugs by Old Age Psychiatrists in the treatment of psychotic and behavioural symptoms in patients with dementiaAging & Mental Health, 2001
- Psychometric Characteristics of the Minimum Data Set II: ValidityJournal of the American Geriatrics Society, 1998
- The Neuropsychiatric InventoryNeurology, 1994
- Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reportedPublished by American Medical Association (AMA) ,1989
- Agitated Behaviors in the Elderly: I. A Conceptual ReviewJournal of the American Geriatrics Society, 1986